Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New epothilone derivatives in early development at Novartis

Aug. 11, 2004

Japanese researchers prepare and test a new antineoplastic antibiotic

Aug. 11, 2004

New KDR and FGFR inhibitors with potential in solid tumor therapy

Aug. 11, 2004

Yakult Honsha and Taiho to copromote oxaliplatin in Japan

Aug. 11, 2004

GlycoGenesys enters agreements to close on funding from institutions

Aug. 11, 2004

PEP-005 shows high selectivity against leukemia

Aug. 11, 2004

BMS scientists design new HER inhibitors for cancer therapy

Aug. 10, 2004

Chemotherapeutic agents target microtubules synergistically

Aug. 10, 2004

Progression of ASCENT trial of DN-101 plus Taxotere for AIPC

Aug. 10, 2004

First chemotherapy combination study for KRX-0401

Aug. 10, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...